¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : ¼­¿ï, ÄÚ¿¢½º

±³À°ÁÖÁ¦ : KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3452-7265  

À̸ÞÀÏ : ksn@ksn.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 33 ½Ã°£ 45ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í ¡áȸ¿ø: »çÀü(100,000)/ÇöÀå(150,000) ¡áºñȸ¿ø: »çÀü(150,000)/ ÇöÀå(200,000) ¡áFellow,Resident,Trainee,Student,Nurse,etc: »çÀü(50,000)/ ÇöÀå(35,000) *Medical Student: ¸éÁ¦

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ Auditorium 10:40~11:30 Membranous Nephropathy – Beyond PLA2R Sanjeev Sethi(Mayo Clinic) Çʼö

±³À°½Ã°£ 04¿ù 29ÀÏ Auditorium 15:30~16:00 ³ëÀÎ Áø·á/ÀÇ·á¿¡ ÀÖ¾î °í·ÁÇØ¾ß ÇÒ À±¸®¿Í ¿¬¸íÀÇ·á°áÁ¤ ÀÌÀº¿µ(ºÎ»ê °¡Å縯´ëÇб³) Çʼö

±³À°½Ã°£ 04¿ù 29ÀÏ Auditorium 16:00~16:25 ³ëÀÎ ¸»±â½ÅºÎÀü ȯÀÚÀÇ µ¹º½°ú Ä¡·á¿¡ ÀÖ¾î À±¸®Àû °í·Á»çÇ× ½Å¼ºÁØ(µ¿±¹´ëÇб³ Àϻ꺴¿ø) Çʼö

±³À°½Ã°£ 04¿ù 29ÀÏ Auditorium 16:25~16:50 ³ëÀÎ ¸»±â½ÅºÎÀü ȯÀÚÀÇ Ä¡·á°áÁ¤ ¼±ÀοÀ(¿¹¼öº´¿ø) Çʼö

±³À°½Ã°£ 04¿ù 29ÀÏ Auditorium 16:50~17:15 ³ëÀÎ ¸»±â½ÅºÎÀü ȯÀÚÀÇ ¿¹ÈÄ Æò°¡ ¹× º¸Á¸Àû µ¹º½ÀÇ ½ÇÁ¦ ±è¼­¸°(¾ç»êºÎ»ê´ëÇб³º´¿ø) Çʼö

Åä·Ð 04¿ù 29ÀÏ Auditorium 17:15~17:30 Panel Discussion All Speaker( ) Çʼö

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 08:30~09:00 Green Nephrology: Its Relevance in Asia Anoushka Krishnan(Royal Perth Hospital)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 09:00~09:30 Point of Care Device for Peritoneal Dialysis- Does It Make PD Greener? Muh Geot Wong(The University of Sydney)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 09:30~10:00 Greenness and Kidney? - Epidemiological Studies on the Relationship Between Green Space and Kidney Diseases ÀÌȯÈñ(ºÎ»ê´ëÇб³)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 10:00~10:30 Risk of Air Pollution, Environmental Chemicals, and Climate Changes on Kidney Disease Outcomes ÀÌÁ¤È¯(¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 11:30~12:20 Use of Sharesource in home-based therapy ÀÌÁ¤È¯(¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)

½Ä»ç 04¿ù 29ÀÏ Room 1 12:20~12:50 Lunch Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 12:50~13:20 Molecular Mechanisms in Inter-Organ Crosstalk (Kidney-Lung Axis) Yohei Komaru(Washington University)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 13:20~13:50 An Update on Management of Cardiorenal Syndrome Ruslinda Mustafar(Universiti Kebangsaan)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 13:50~14:20 Impact of Chronic Kidney Disease on Brain ±æÈ¿¿í(¼øõÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 14:20~14:50 Renohepatic Crosstalk: Mechanisms and therapeutic Approaches ½ÅÈ£½Ä(°í½Å´ëÇб³ º¹À½º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 15:30~16:00 Prevention and Diagnosis of AKI: Community-and Hospital-Acquired Aki Nattachai Srisawat(Chulalongkorn University)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 16:00~16:30 Medical Management of AKI ±è¼¼Áß(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 16:30~17:00 Renal Support for Acute Kidney Injury in Critically Ill Patients Manish Kaushik(Singapore General Hospital)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 1 17:00~17:30 Biomarker Utilization in AKI Zoltán H Endre(University of New South Wales Kensington NSW)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 08:30~08:40 Nocturnal Systolic Blood Pressure Dipping and Progression of Chronic Kidney Disease ¹Úöȣ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 08:40~08:50 Upregulation of Adipose Tissue (AT) Fatty Acid-Binding Protein 4 (FABP4) in Chronic Kidney Disease (CKD) Patients: Implications for Dysfunctional Vascular Cells ³ëÇöÁø(¼øõÇâÀÇ´ë ¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 08:50~09:00 Use of Aspirin and Risk of Initial Cardiovascular Events and Bleeding in CKD G3-G4 patients: A Nationwide Cohort Study in South Korea ±èÀ翵(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 09:00~09:10 Therapeutic role of colostrum-derived exosome in chronic kidney disease Á¤¼®¹Î(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 09:10~09:20 Association of plant protein intake and risk of incident chronic kidney disease: The UK Biobank study Çã°¡¿µ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 09:20~09:30 PTEN-induced kinase 1 has association with renal aging process through cGAS -STING pathway ÇϹÎÈñ(ºÐ´çÂ÷º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 09:30~09:40 Effect of pharmacological enhancement of circadian clock in chronic kidney disease. ±è¸í±Ô(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 09:40~09:50 Cause-specific biomarker of chronic kidney disease by integrating genomics and metabolomics in Korean population °­¹Î¿ì(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 09:50~10:00 The Association Between Potassium Intake and Risk of Chronic Kidney Diseases ±èÈ¿Á¤(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 10:00~10:10 The role of resident renal fibroblast on renal fibrosis and crosstalk with tubular epithelial cells À̼±È­(°­¿ø´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 10:10~10:20 Bioinformatics investigation of potential natural bioactive compounds targeting TGF-¥â1 receptor to treat kidney fibrosis Reny Rosalina(Faculty of Mathematics and Natural Sciences Universitas Palangka Raya)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 10:20~10:30 Efficacy and safety of oral difelikefalin in stage 3-5 chronic kidney disease patients with moderate-to-severe pruritus: a response analysis from a randomised, placebo-controlled, phase 2 trial Warren Wen(Cara Therapeutics)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 11:30~12:20 Ferric Citrate with CKD-MBD from real-world perspectives MASAHIDE MIZOBUCHI(Showa University School of Medicine Japan)

½Ä»ç 04¿ù 29ÀÏ Room 2 12:20~12:50 Lunch Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 12:50~13:20 Choice of RRT Modality In the Elderly Á¶ÀåÈñ(°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 13:20~13:50 Frailty in Elderly ESKD Patient: What Can We Do? È«À¯¾Æ(°¡Å縯´ëÇб³ ´ëÀü¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 13:50~14:20 Vascular Access in the Elderly HD Patients Toshihide Naganuma(Osaka City University)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 14:20~14:50 Dialysis Withdrawal in ESKD Yi-Wen Chiu(Kaohsiung Medical University)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 15:30~15:40 Increased Right Ventricular Pressure as a Predictor of Acute Decompensated Heart Failure in End-Stage Renal Disease Patients on Maintenance Hemodialysis ¹Úº´È­(°í½ÅÀÇ´ë º¹À½º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 15:40~15:50 Dialysis Adequacy and Incident Atrial Fibrillation in Hemodialysis Patients Çã°¡¿µ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 15:50~16:00 Loss of Cutibacterium is responsible for CKD-associated pruritus in patients undergoing dialysis ÀÌÁ¤°Ç(¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ(õ¾ÈÄ·ÆÛ½º))

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 16:00~16:10 The impact of severe depression on the survival of older patients with end-stage kidney disease ÀÌ¿µÈ¯(°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 16:10~16:20 The comparison of humoral response between third and forth doses of COVID-19 vaccines in end-stage renal disease on hemodialysis ±è´ë±Ô(°­µ¿°æÈñ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 16:20~16:30 Association of insomnia with the risk of cardiovascular disease and all-cause mortality in patients with incident ESKD ±èÇü¿ì(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 16:30~16:40 Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients ¹éÁöÇö(ºÐ´çÂ÷º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 16:40~16:50 SURVIVAL STUDY OF DIALYSIS PATIENTS WITH CONCOMITANT CARDIOVASCULAR DISEASES Olimkhon Sharapov(Republican Specialized Scientific Practical Medical Center of Nephrology and Kidney transplantation)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 16:50~17:00 Blocking Plasminogen activator inhibitor-1 (PAI-1) ameliorates the functional and structural deterioration of peritoneum in animal model of peritoneal dialysis (PD) ±è´Þ¾Æ(ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ·á¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 2 17:00~17:10 The Perception of End Stage Renal Disease Patients regarding Peritoneal Dialysis: The Initial Phase for an Information Package Development Annie Rose Ammar(Zamboanga City Medical Center)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 08:30~09:00 New therapies for Patients With Type 2 Diabetes and Obesity Hiddo L Heerspink(University Medical Center Groningen)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 09:00~09:30 TGF-beta Signaling in DKD Kyung Lee(Icahn School of Medicine)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 09:30~10:00 The Role of Lactic Acidosis on Renal Fibrosis and Its Dysfunction in DKD ±è¿øÈ£(Áúº´°ü¸®Ã» ±¹¸³º¸°Ç¿¬±¸¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 10:00~10:30 Klotho Protects Diabetic Nephropathy via Regulating Podocyte Ca2+-Permeable Channels Â÷½Â±Ô(¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 12:50~13:20 High-Performance Membrane Dialyzers in Hemodialysis Patients Ikuto Masakane(Yabuki Hospital)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 13:20~13:50 Management of High Output AVF Failure ¹ÚÈƼ®(°¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 13:50~14:20 Clinical Usage of Ultrasonography in AVF ±èÇö¼÷(ÇѸ²ÀÇ´ë Ãáõ¼º½Éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 14:20~14:50 Parenteral Nutrition of Hemodialysis Patients ±è¼Ò¹Ì(´Ü±¹´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 15:30~16:00 How to Apply Genetics to the Kidney Transplant Recipients ÀÌ»óÈ£(°­µ¿°æÈñ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 16:00~16:30 Is there significant advance in using genetics for Pediatric Patients? °­Èñ°æ(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 16:30~17:00 Genetics in Research – Towards Understanding Pathophysiology Morgan Grams(NYU Langone)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 3 17:00~17:30 Genetics in CKD – Where are We and Where are We going? Outcomes from the 2021 KDIGO Controversies Conference on Genetics in CKD Andrew Mallett(James Cook University)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 08:30~09:00 Impact of RRT on Clinical Outcomes in AKI ÀåÇý·Ã(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 09:00~09:30 Obesity and Sepsis Associated AKI ÀÌÈ«¿­(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 09:30~10:00 Optimal Blood Pressure Target for the Patient with Septic AKI: Lower Á¤Ä¡·®(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 10:00~10:30 Optimal Blood Pressure Target for the Patient with Septic AKI: Higher ±è¿¹¸²(°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 12:50~13:20 Normal Reference Values for Glomerular Filtration Rate in Older Adults: Fixed or Age Adjusted? ¹Ú¹«¿ë(¼øõÇâ´ëÇб³ ºÎ¼Ó ºÎõº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 13:20~13:50 Common Glomerular Disorders in Older Population ÀüÁø¼®(¼øõÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 13:50~14:20 Conservative or Dialysis Treatment in Stage 5 CKD Old Adults: Insights from Cochrane Reviews ÀÌÁØ¿µ(¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 14:20~14:50 Are Old Adults Safe and Suitable Candidate Donors or Recipients for Kidney Transplantation ? ¹éÃæÈñ(¼­¿ï ¾Æ»êº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 15:30~15:50 Diabetes Factsheet in Korea: An Appraisal of Current Status ±è¹Ì°æ(°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 15:50~16:10 Epidemiologic Characteristics of Diabetic Kidney Disease in Korea ÇÑ»ó¿±(ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 16:10~16:30 KSN 2023 Practical Recommendations for Management of Diabetic Kidney Disease Á¤¼ºÁø(°¡Å縯´ëÇб³ ¿©Àǵµ¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 4 16:30~16:50 National Chronic Disease Strategy on Diabetes and Diabetic Kidney Disease ±Ç»óÈñ(Áúº´°ü¸®Ã» ±¹¸³º¸°Ç¿¬±¸¿ø)

Åä·Ð 04¿ù 29ÀÏ Room 4 16:50~17:05 Panel Discussion All Speaker( )

ÈÞ½Ä 04¿ù 29ÀÏ Room 4 17:05~17:10 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 08:30~09:00 [2021³â ¿¬±¸È¸Áö¿ø»ç¾÷] ±¹¼ÒºÐÀý»ç±¸Ã¼°æÈ­ÁõÀÇ À¯ÀüÀû ¿øÀΠŽ»ö °­Èñ°æ(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 09:00~09:30 [2021³â ¿¬±¸È¸Áö¿ø»ç¾÷] Åõ¼®Ä¡·á¹æ¹ý¿¡ µû¸¥ ¾ËºÎ¹Î ¼Ò½Ç°ú ´Ü¹é°áÇտ䵶 Á¦°Å È¿°ú ºñ±³ ±è¾ç±Õ(°­µ¿°æÈñ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 09:30~10:00 [2021³â ¿¬±¸È¸Áö¿ø»ç¾÷] Ç÷¾×Åõ¼®È¯ÀÚ¿¡¼­ Ç÷°üÅë·ÎÀÇ ÀüÇâÀû ÄÚȣƮ ±¸¼ºÀ» ÅëÇÑ ÃßÀû°üÂû¿¬±¸ ±èµµÇü(ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 10:00~10:30 [2022³â Çùµ¿¿¬±¸°úÁ¦] Clinical Data Warehouse(CDW)À» È°¿ëÇÑ ¼ö¼ú ÈÄ ±Þ¼º ½Å¼Õ»óÀÇ ¹ß»ý ¹× Àå±âÀûÀÎ ½ÅÀåÀÇ ¿¹ÈÄ ¿¹Ãø ÀΰøÁö´É ¸ðµ¨ À±ÇýÀº(°¡Å縯´ëÇб³ ÀÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 12:50~13:20 The Use of Bone Turn-Over Marker in CKD ÀüÀ±°æ(ºÎ»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 13:20~13:50 Pericardial Fat, Metabolic Abnormality and Cardiovascular Disease ÃÖ¼ºÈñ(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 13:50~14:20 Triglycerides - Does It Matter in CKD? ¼­»óÇå(Àü³²´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 14:20~14:50 Obesity Control in CKD À±ÇØ·æ(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 15:30~16:00 Relationship Between Resistant Hypertension and Renal Outcome ¹Ú¼ºÇÏ(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 16:00~16:30 Current Status of RDN and Perspectives for Renal Protection ±èÂùÁØ(°¡Å縯´ëÇб³ ÀÇÁ¤ºÎ¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 16:30~17:00 Which BP Metrics Should Be Used in Patients on Dialysis? Á¤Áö¿ë(°¡Ãµ´ë ±æº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Room 5 17:00~17:30 Clinical Implication of BP Variability in CKD ÁöÁ¾Çö(°­³² ¼¼ºê¶õ½ºº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29
´ÙÀ½±Û ´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 107 2024-04-30
20619 °æ³² »ï¼ºÃ¢¿øº´¿ø (¿Â¶óÀÎ)»ï¼ºÃ¢¿ø Ambulatory Pediatrics 2024 : 2024-06-29 0 95 2024-04-30
20618 °æºÏ Á¦8Â÷ ´ëÇѸðüžÆÀÇÇÐȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­ÁÂ(¿µ³²) : 2024-06-29 0 35 2024-04-30
20617 ¼­¿ï °Ç±¹´ëÇб³º´¿ø 2024 KUMC Precision Medicine Lung Cancer Conference : 2024-06-28 0 29 2024-04-30
20616 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ÀûÇ÷±¸Áúȯ¿¬±¸ ½ÉÆ÷Áö¾ö : 2024-06-28 0 47 2024-04-30
20615 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 35 2024-04-30
20614 ¼­¿ï 2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 31 2024-04-30
20613 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 66 2024-04-29
20612 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 46 2024-04-29
20611 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(2ÀÏÂ÷) : 2024-06-22 0 52 2024-04-29
20610 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 21ÀÏ ±Ý¿äÁý´ãȸ(ÀÌ°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-21 0 45 2024-04-29
20609 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¾È¸é¸¶ºñ) : 2024-06-21 0 35 2024-04-29
20608 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(1ÀÏÂ÷) : 2024-06-21 0 43 2024-04-29
20607 ¼­¿ï 2024 ´ëÇÑȯ°æõ½ÄÆóÁúȯÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-21 0 48 2024-04-29
20606 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¿Ü·¡¿¡¼­ °£´ÜÇÏ°Ô ÇÒ ¼ö ÀÖ´Â À½¼ºÄ¡·á : 2024-06-20 0 34 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷